Join to view full profile
600 N Wolfe StBaltimore, MD 21287
Phone+1 410-955-8964
Dr. Levitsky is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991- Johns Hopkins UniversityResidency, Internal Medicine, 1984 - 1987
- Johns Hopkins University School of MedicineClass of 1984
Certifications & Licensure
MD State Medical License 1987 - 2022
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2002
Publications & Presentations
PubMed
- 103 citationsImaging CAR T cell therapy with PSMA-targeted positron emission tomography.Il Minn, David Jeffrey Huss, Hye Hyun Ahn, Tamara M. Chinn, Andrew Park
Science Advances. 2019-07-01 - 165 citationsRapid activation of tumor-associated macrophages boosts preexisting tumor immunity.Sabine Hoves, Chia Huey Ooi, Carsten Wolter, Hadassah Sade, Stefan Bissinger
The Journal of Experimental Medicine. 2018-03-05 - 9 citationsParadoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging.Deepak K. Kadayakkara, Michael J. Korrer, Jeff W.M. Bulte, Hyam I. Levitsky
Cancer Research. 2015-01-01
Press Mentions
- As Allogeneic Cell Therapy Approaches Flourish, Century Loads up $160M to Scale iPSC Platform for CAR-T, CAR-NKMarch 3rd, 2021
Century Therapeutics Launches with USD 250M Financing for Induced Pluripotent Stem Cell (iPSC) Allogeneic Cell Therapy PlatformJuly 1st, 2019
Bayer Powers Versant Cell Therapy Startup to $250M RoundJuly 1st, 2019
Grant Support
- Immunologic Targets In Myeloid LeukemiaNational Cancer Institute2010–2012
- Non-Invasive Quantification Of Vaccine-Mediated Antigen Delivery ToNational Cancer Institute2010–2011
- Regulatory T Cells In B Cell LymphomaNational Cancer Institute2008–2011
- Human ImmunologyNational Cancer Institute2006–2010
- Vaccination In Combination With Imatinib Mesylate For Chronic Myeloid LeukemiaNational Center For Research Resources2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
